Qube Research & Technologies LTD Aclaris Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 940,752 shares of ACRS stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
940,752
Previous 1,212,260
22.4%
Holding current value
$1.14 Million
Previous $1.5 Million
31.2%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ACRS
# of Institutions
100Shares Held
52.2MCall Options Held
32.4KPut Options Held
3.3K-
Bml Capital Management, LLC Zionsville, IN13MShares$15.7 Million10.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.69MShares$5.67 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.34MShares$4.04 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.32MShares$4.02 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.75MShares$3.33 Million0.09% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $80.7M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...